- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00419289
Optimizing the Effect of COPD Rehabilitation
January 4, 2007 updated by: Glostrup University Hospital, Copenhagen
Rehabilitation of COPD Patients: Can the Effect be Prolonged by Follow-up and Continued Rehabilitation
Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme.
However, the effect of the programme tends to attenuate with time.
Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme according to guidelines of the Danish Society of Pulmonary Medicine.
However, the effect of programme tends to attenuate with time.
Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.
Study Type
Interventional
Enrollment
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 2600
- Department of Internal Medicine M, Glostrup University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- FEV1 < 60% of expected
Exclusion Criteria:
- Other severe chronic conditions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Disease specific Quality of Life
|
|
Work Capacity
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Number of days admitted to hospital
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Study Completion
June 1, 2008
Study Registration Dates
First Submitted
January 4, 2007
First Submitted That Met QC Criteria
January 4, 2007
First Posted (Estimate)
January 8, 2007
Study Record Updates
Last Update Posted (Estimate)
January 8, 2007
Last Update Submitted That Met QC Criteria
January 4, 2007
Last Verified
January 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KA20060179
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on follow-up rehabilitation of participants with COPD
-
University of British ColumbiaWithdrawn
-
University Hospitals Bristol and Weston NHS Foundation...CompletedPost Traumatic Stress DisorderUnited Kingdom
-
Medical College of WisconsinRecruitingFollicular Lymphoma | Multiple Myeloma | Burkitt Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Lymphoma, Small Lymphocytic | Diffuse Large B Cell Lymphoma | Central Nervous System Lymphoma | Lymphomas Non-Hodgkin's B-CellUnited States
-
Institute of Psychiatry and Neurology, WarsawUnknown
-
Clínica de Occidente S.AActive, not recruiting
-
Pontificia Universidad Catolica de ChileUniversity of Technology, SydneyCompletedCardiovascular Diseases | Hypertension | Type 2 Diabetes Mellitus | Dyslipidemias | Medication Adherence | Drug UseChile
-
Rabin Medical CenterUnknown
-
Martina Hansen's HospitalHelse Sor-Ost; London School of Economics and Political ScienceUnknownRheumatoid Arthritis | Treatment ComplianceNorway
-
Washington University School of MedicineCompletedColposcopy | Abnormal Pap SmearUnited States
-
University Hospital, Strasbourg, FranceWithdrawnPatient Admitted to Intensive Care Unit for COVID-19France